John Northcott

John Northcott serves as Chief Commercial Officer at Arvinas. Mr. Northcott has extensive U.S. and global commercial leadership experience, including both pre-launch planning and on-market commercialization in oncology and other therapeutic areas. Prior to Arvinas, Mr. Northcott served as Chief Commercial Officer of Nektar Therapeutics. From 2015 to 2019, he served as the Chief Commercial Officer of Pharmacyclics, where he led the successful commercialization of Imbruvica®, with functional responsibility for commercial strategy, marketing, market access, sales, analytics, and commercial operations.

From 2013 to 2015, Mr. Northcott was Chief Commercial Officer at Lexicon Pharmaceuticals where he led commercial strategy and operations for all products and therapeutic areas. From 2007 to 2013, Mr. Northcott held commercial leadership roles in both U.S. and global marketing for Avastin® with Genentech and the Roche Group. Additionally, Mr. Northcott held prior management positions in sales and marketing in a variety of therapeutic areas at pharmaceutical companies including Merck and Pfizer.

Mr. Northcott received his B.A. in Business Administration from St. Francis Xavier University.